Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 71,286 | 119,709 | 209,948 | 684,636 | 113,938 |
Marketable Securities | 639,355 | 825,283 | 267,166 | 187,213 | 369,616 |
Receivables | 43,178 | 36,938 | 37,030 | 25,309 | 23,412 |
Inventories | 21,223 | 29,697 | 21,817 | 8,581 | N/A |
TOTAL | $808,393 | $1,046,651 | $554,025 | $927,759 | $516,786 |
Non-Current Assets | |||||
PPE Net | 41,959 | 33,344 | 30,700 | 34,129 | 38,361 |
Investments And Advances | 84,319 | 161,269 | 557,529 | 677,873 | 64,406 |
Other Non-Current Assets | 114,579 | 108,638 | 109,971 | 78,632 | 88,141 |
TOTAL | $240,857 | $303,251 | $698,200 | $790,634 | $190,908 |
Total Assets | $1,049,250 | $1,349,902 | $1,252,225 | $1,718,393 | $707,694 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 30,278 | 16,851 | N/A | N/A | N/A |
Accounts payable and accrued liabilities | 4,710 | 2,729 | 8,333 | 4,370 | 4,793 |
Accrued Expenses | 127,992 | 131,123 | 121,829 | 105,938 | 88,706 |
Other current liabilities | 39,198 | 17,285 | N/A | N/A | N/A |
TOTAL | $214,923 | $183,234 | $149,765 | $130,802 | $106,482 |
Non-Current Liabilities | |||||
Long Term Debt | 208,535 | 122,232 | N/A | N/A | N/A |
Deferred Revenues | 812 | 4,667 | 11,510 | 12,559 | 6,160 |
Other Non-Current Liabilities | 490,391 | 516,135 | 106,659 | 88,904 | 96,940 |
TOTAL | $703,718 | $651,991 | $131,725 | $117,503 | $136,853 |
Total Liabilities | $918,641 | $835,225 | $281,490 | $248,305 | $243,335 |
Shareholders' Equity | |||||
Shares Outstanding, K | 61,232 | 59,984 | 59,203 | 57,958 | 54,027 |
Common Shares | 61 | 60 | 59 | 58 | 49 |
Retained earnings | -2,339,942 | -1,832,958 | -1,275,441 | -631,356 | -945,238 |
Other shareholders' equity | -3,495 | -10,443 | -4,133 | -5,214 | -2,535 |
TOTAL | $130,609 | $514,677 | $970,735 | $1,470,088 | $464,359 |
Total Liabilities And Equity | $1,049,250 | $1,349,902 | $1,252,225 | $1,718,393 | $707,694 |